Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex

被引:59
作者
Laurini, Erik [1 ]
Marson, Domenico [1 ]
Aulic, Suzana [1 ]
Fermeglia, Maurizio [1 ]
Pricl, Sabrina [1 ,2 ]
机构
[1] Univ Trieste, Mol Biol & Nanotechnol Lab MolBNL UniTS, DEA, I-34127 Trieste, Italy
[2] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biophys, PL-90136 Lodz, Poland
关键词
SARS-CoV-2 spike protein; ACE2; receptor-binding domain; molecular dynamics; computational alanine-scanning mutagenesis; molecular mechanics/Poisson-Boltzmann surface area; free energy of binding; INTERACTION ENTROPY; KIT MUTATIONS; BCR-ABL; INHIBITOR; RECEPTOR; RESISTANCE; BINDING; GIST; DASATINIB; MECHANISM;
D O I
10.1021/acsnano.0c04674
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The recent emergence of the pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent for the coronavirus disease 2019 (COVID-19), is causing a global pandemic that poses enormous challenges to global public health and economies. SARS-CoV-2 host cell entry is mediated by the interaction of the viral transmembrane spike glycoprotein (S-protein) with the angiotensin-converting enzyme 2 gene (ACE2), an essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis. Accordingly, this work reports an atomistic-based, reliable in silico structural and energetic framework of the interactions between the receptor-binding domain of the SARS-CoV-2 S-protein and its host cellular receptor ACE2 that provides qualitative and quantitative insights into the main molecular determinants in virus/receptor recognition. In particular, residues D38, K31, E37, K353, and Y41 on ACE2 and Q498, T500, and R403 on the SARS-CoV-2 S-protein receptor-binding domain are determined as true hot spots, contributing to shaping and determining the stability of the relevant protein-protein interface. Overall, these results could be used to estimate the binding affinity of the viral protein to different allelic variants of ACE2 receptors discovered in COVID-19 patients and for the effective structure-based design and development of neutralizing antibodies, vaccines, and protein/protein inhibitors against this terrible new coronavirus.
引用
收藏
页码:11821 / 11830
页数:10
相关论文
共 50 条
[41]   Angiotensin-converting enzyme 2 and hepatic SARS-CoV-2 infection: Regulation, association, and therapeutic implications [J].
Luo, Yu-Wei ;
Huang, Ai-Long ;
Tang, Kai-Fu .
WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (06)
[42]   Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection [J].
Chodick, Gabriel ;
Nutman, Amir ;
Yiekutiel, Naama ;
Shalev, Varda .
JOURNAL OF TRAVEL MEDICINE, 2020, 27 (05)
[43]   Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy [J].
Lennol, Matthew P. ;
Garcia-Ayllon, Maria-Salud ;
Esteban, Mariano ;
Garcia-Arriaza, Juan ;
Saez-Valero, Javier .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[44]   Screened Fv-Antibodies against the Angiotensin-Converting Enzyme 2 (ACE2) Receptor Neutralizing the Infection of SARS-CoV-2 [J].
Jung, Jaeyong ;
Kwon, Soonil ;
Sung, Jeong Soo ;
Bae, Hyung Eun ;
Kang, Min-Jung ;
Jose, Joachim ;
Lee, Misu ;
Pyun, Jae-Chul .
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (12) :3914-3920
[45]   Peptide-Based Inhibitors of Protein-Protein Interactions (PPIs): A Case Study on the Interaction Between SARS-CoV-2 Spike Protein and Human Angiotensin-Converting Enzyme 2 (hACE2) [J].
Rakhmetullina, Aizhan ;
Zielenkiewicz, Piotr ;
Odolczyk, Norbert .
BIOMEDICINES, 2024, 12 (10)
[46]   Characterization of the angiotensin-converting enzyme 2 (ACE2), the main receptor for the SARS-CoV-2 virus [J].
Jami, Giti ;
Ataee, Mehrnaz ;
Esmaeili, Vahide ;
Chamani, Sajjad ;
Rezaei, Azam ;
Naghizadeh, Ali .
AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 12 (03) :24-44
[47]   ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases Ramifications for the Control of SARS-CoV-2 [J].
Sharma, Ravindra K. ;
Stevens, Bruce R. ;
Obukhov, Alexander G. ;
Grant, Maria B. ;
Oudit, Gavin Y. ;
Li, Qiuhong ;
Richards, Elaine M. ;
Pepine, Carl J. ;
Raizada, Mohan K. .
HYPERTENSION, 2020, 76 (03) :651-661
[48]   Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting [J].
Sharifkashani, Sourena ;
Bafrani, Melika Arab ;
Khaboushan, Alireza Soltani ;
Pirzadeh, Marzieh ;
Kheirandish, Ali ;
Bali, Hanie Yavarpour ;
Hessami, Amirhossein ;
Saghazadeh, Amene ;
Rezaei, Nima .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 884
[49]   Human angiotensin-converting enzyme 2-specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants [J].
Lu, Tong ;
Zhang, Chengcheng ;
Li, Zhengqi ;
Wei, Vi ;
Sadewasser, Anne ;
Yan, Yan ;
Sun, Lin ;
Li, Jian ;
Wen, Vihui ;
Lai, Shimin ;
Chen, Changhui ;
Zhong, Hua ;
Jime, Marta Reyes ;
Klar, Richard ;
Schell, Monika ;
Raith, Stefanie ;
Michel, Sven ;
Ke, Bixia ;
Zheng, Huanying ;
Jaschinski, Frank ;
Zhang, Nan ;
Xiao, Haipeng ;
Bachert, Claus ;
Wen, Weiping .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (04) :1044-1059
[50]   Mulberrofuran G, a Mulberry Component, Prevents SARS-CoV-2 Infection by Blocking the Interaction between SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor [J].
Kim, Young Soo ;
Kim, Buyun ;
Kwon, Eun-Bin ;
Chung, Hwan-Suck ;
Choi, Jang-Gi .
NUTRIENTS, 2022, 14 (19)